Title: Lipase-Colipase Inhibitor (H0506B)

Inventor: Charlotte Erlanson-Albertsson

Abstract
The invention relates to novel colipase-lipase inhibitor to be used in the treatment or prophylaxis of obesity. The compounds have been tested in different models, in vitro as well as in vivo, with excellent results.

Application
The inhibitor has great potential in the treatment or prophylaxis of obesity, high blood levels and diabetes type 2.

Patent status

View detailed description of the invention >>

Licensing contact
Sten Trolle, CEO, Lund University Technology Group
sten.trolle@forskarpatent.com
Phone: +46 46 286 36 01

Keywords
Obesity, colipase-lipase inhibitor